SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0000950170-24-079281
Filing Date
2024-07-01
Accepted
2024-07-01 08:40:03
Documents
4

Document Format Files

Seq Description Document Type Size
1 425 ktra_425_20240701_corp_u.htm 425 82029
2 EX-99.1 ktra-ex99_1.htm EX-99.1 42497
3 GRAPHIC img40499469_0.jpg GRAPHIC 123916
4 GRAPHIC img40499469_1.jpg GRAPHIC 115627
  Complete submission text file 0000950170-24-079281.txt   456558
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121 (858) 350-4364
Kintara Therapeutics, Inc. (Filed by) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 425
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121 (858) 350-4364
Kintara Therapeutics, Inc. (Subject) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 425 | Act: 34 | File No.: 001-37823 | Film No.: 241088316
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)